Showing results (571-580 of 580) with videos related to

Sort By:
Pageof 58
You have reached the last page of results.This site can display upto 580 results.
International Journal of Cancer|December 10, 2015
Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancerJ M Nabholtz, N Chalabi, N Radosevic-Robin, et al.
British Journal of Cancer|June 9, 1999
European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables. Breast Cancer Somatic Genetics ConsortiumV Launonen, K Laake, P Huusko, et al.
Cancer Research|March 21, 1998
Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parametersC M Phelan, A Borg, M Cuny, et al.
Human Molecular Genetics|December 26, 2001
DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesisM Esteller, M F Fraga, M Guo, et al.
Breast Cancer Research and Treatment|April 6, 2012
Rare germline large rearrangements in the BRCA1/2 genes and eight candidate genes in 472 patients with breast cancer predispositionE Rouleau, B Jesson, A Briaux, et al.
Cancer Genomics & Proteomics|January 9, 2009
Comparative clinical and transcriptomal profiles of breast cancer between French and South Mediterranean patients show minor but significative biological differencesN Chalabi, D J Bernard-Gallon, Y J Bignon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2S R Lakhani, B A Gusterson, J Jacquemier, et al.
Der Urologe. Ausg. A|April 20, 2018
[Lutetium-177-PSMA radioligand therapy : Consensus within the framework of GKV-funded care between the university hospitals in Aachen, Bonn, Düsseldorf, Essen, and Cologne and the MDK Nordrhein]H Ahmadzadehfar, P Albers, A Bockisch, et al.
Journal of the National Cancer Institute|August 13, 1998
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutationsS R Lakhani, J Jacquemier, J P Sloane, et al.
BJU International|September 16, 2010
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT studyAnita V Mitra, Elizabeth K Bancroft, Yolanda Barbachano, et al.
Pageof 58